← Back to Clinical Trials
Recruiting NCT07276646

NCT07276646 Perioperative Opioid-sparing Effect of Retrosuperior Costotransverse Ligament Block Versus Erector Spinae Block in Laparoscopic Cholecystectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07276646
Status Recruiting
Phase
Sponsor Zagazig University
Condition Perioperative Analgesia
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-12-10
Primary Completion 2026-06-10

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 64 Years
Study Type INTERVENTIONAL
Interventions
Retrosuperior costotransverse ligament block groupErector spinae block group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-12-10 with a primary completion date of 2026-06-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the analgesic effect of retro superior costotransverse ligament space block vs erector spinae plane block to Achieve high-quality perioperative opioid-sparing effect and postoperative analgesia after laparoscopic cholecystectomy with optimum hemodynamic stability and high patient and surgeon satisfaction

Eligibility Criteria

Inclusion Criteria: 1. patient acceptance 2. Age: 21-64 years old. 3. Sex: both sexes. 4. Physical status: ASA I \& II. 5. Body mass index (BMI): 18.5 - 30 kg/m2. 6. Type of operations: elective laparoscopic cholecystectomy. 7. Duration of surgery not more than 2 hours. Exclusion Criteria: 1. Known hypersensitivity to lidocaine or bupivacaine. 2. Patients with respiratory insufficiency. 3. Coagulation disorders or taking drugs affect surgical hemostasis. 7\. Patients with pre-existing neurological deficits. 8. Uncooperative patient or with altered mental status. 9. Patient with advanced cardiovascular or respiratory diseases

Contact & Investigator

Central Contact

Dina Salem, MD

📞 01099333513

Frequently Asked Questions

Who can join the NCT07276646 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 64 Years, studying Perioperative Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07276646 currently recruiting?

Yes, NCT07276646 is actively recruiting participants. Visit ClinicalTrials.gov or contact Zagazig University to inquire about joining.

Where is the NCT07276646 trial being conducted?

This trial is being conducted at Zagazig, Egypt.

Who is sponsoring the NCT07276646 clinical trial?

NCT07276646 is sponsored by Zagazig University. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology